Foghorn Therapeutics Inc. (FHTX) Operating income 2019–2025
Foghorn Therapeutics Inc. (FHTX) annual operating income history from SEC filings — each fiscal year as reported.
-$86.4MFY2025 · since FY2019: -$51.1M → -$86.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.4M | +15.9% |
| FY2024 | -$102.7M | +4.8% |
| FY2023 | -$107.9M | +7.9% |
| FY2022 | -$117.1M | -16.3% |
| FY2021 | -$100.7M | -47.0% |
| FY2020 | -$68.5M | -34.2% |
| FY2019 | -$51.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice